Company / EPS (Diluted)
DNA X, Inc. EPS (Diluted) History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.02
FY2024
5-year range
-$6.48 / -$0.02
FY2020-FY2024
Trend
+95.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-6.48 to $-0.02 over the past 3 years.
Based on SEC 10-K filings.
-0.02 in FY2024.
Improved from $-6.48 to $-0.02 over the past 3 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (diluted) increased 95.9% year-over-year.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.02 | +95.9% |
| FY2023 | -$0.49 | - |
| FY2022 | - | - |
| FY2021 | -$6.48 | -366.2% |
| FY2020 | -$1.39 | +45.9% |
| FY2019 | -$2.57 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026